Clinical

Dataset Information

0

Conventionally Fractionated Adaptive Radiation Therapy of Bladder Cancer an Individualized Approach


ABSTRACT: This is a single-arm, prospective, Phase II, multi-center clinical trial designed to demonstrate that adaptive radiotherapy for muscle invasive bladder cancer will translate into a decreased rate of acute gastrointestinal toxicity compared with the historically reported rate for non-adaptive intensity modulated radiation therapy (IMRT).

DISEASE(S): Urinary Bladder Neoplasms,Muscle-invasive Bladder Carcinoma

PROVIDER: 2710638 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 6198 | ecrin-mdr-crc
| PRJNA918302 | ENA
| PRJNA515480 | ENA
2020-11-18 | GSE161743 | GEO
| EGAS00001006818 | EGA
2016-09-27 | GSE83239 | GEO
2008-08-20 | E-GEOD-11071 | biostudies-arrayexpress
| PRJNA741257 | ENA
2002-02-11 | E-GEOD-29 | biostudies-arrayexpress
2008-10-25 | E-GEOD-11558 | biostudies-arrayexpress